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ThrombusLeukocytes invade newly formed thrombi through interactions with platelets and ﬁbrin and later contribute
to the removal of ﬁbrin deposits mainly through the action of neutrophil elastase. The present study
attempts to express in quantitative terms the impact of neutrophils on the lytic processes in obliterative
thrombi based on the local presence of elastase-speciﬁc ﬁbrin degradation products (NE-FDP) in relation to
the leukocyte, platelet and ﬁbrin content of thrombi. Immunoﬂuorescent detection of ﬁbrin, NE-FDP and
platelet antigens was performed in sections of thrombi from 28 patients subjected to thrombectomy in
combination with DNA-staining for identiﬁcation of nucleated cells. The digitalized ﬂuorescent microscopic
images were decomposed according to the color channel of each thrombus constituent. The integrated
intensity values for all thrombus constituents were statistically evaluated with correlation, hierarchical
agglomerative clustering , Hotelling's T2 and F-statistics. Association between NE-FDP and leukocyte content
of thrombi is evidenced by a signiﬁcant Pearson correlation coefﬁcient of 0.71 (p=0.00002). Cluster analysis
reveals two classes of thrombi according to NE-FDP, leukocyte and platelet content and also two according to
NE-FDP, leukocyte and ﬁbrin content. When NE-FDP, ﬁbrin and platelet content is normalized to the
leukocyte count in the same thrombus, clusters with platelet-related thrombolytic resistance (inversely
related NE-FDP and platelet content) and advanced cell-dependent thrombolysis (inversely related NE-FDP
and ﬁbrin content) are identiﬁed. These distinct patterns of thrombus constituents are snapshots of
characteristic stages in the cell-dependent thrombolysis, which indicate a clot-stabilizing role for platelets in
this process similar to their impact on the plasmin-dependent lysis.; GPIIb/IIIa, integrin αIIbβ3; NE,
tion products; PBS, phosphate
S, Tris buffered saline.
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Thrombus growth at sites of vascular injury or over atherosclerotic
plaques is initiated by the shear-dependent platelet aggregation
involving the priming adhesive role of the platelet glycoprotein (GP)
Ib receptor and subsequent stabilization of the plug through the
integrin αIIbβ3 (GP IIb/IIIa) activation by soluble agonists [1,2].
Adherent platelets recruit leukocytes from circulating blood, pre-
dominantly neutrophils, representing 76 % of the leukocytes in
thrombi, and monocytes (16 %) [3] followed by activation of thethrombus-bound cells [4]. Upon activation monocytes express tissue
factor and form tissue factor-rich microparticles, which together with
the damaged tissue-derived tissue factor promote ﬁbrin formation as
a scaffold of the growing thrombus [5]. Thrombogenesis is supported
by the platelet activating effects of cathepsin G released in the course
of degranulation of activated neutrophils together with neutrophil
elastase (NE) [6,7]. In contrast to the prothrombotic interplay of
thrombus-bound cells, in later stages of thrombus formation
neutrophil adhesion seems to restrict thrombus growth [8] through
removal of the deposited ﬁbrin, which can be attributed to
phagocytotic activity [9,10] and/or extracellular proteolysis based
on released proteases [11,12]. The major ﬁbrinolytic enzymes of
human leukocytes are known to be NE and cathepsin G [13,14], the
catalytic efﬁciency of NE in ﬁbrin dissolution being ten-fold higher
than that of cathepsin G [15]. Because NE cleaves ﬁbrin at peptide
bonds different from the site of action of plasmin (the major classic
ﬁbrinolytic protease), NE-digested ﬁbrin degradation products (FDP)
can be distinguished immunologically from the plasmin-digested
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speciﬁc FDPs, elevation of the plasma levels of NE-digested FDPs has
been observed in several inﬂammatory disease states [16], but little is
known about the in vivo contribution of NE to the lytic process in
thrombi. The present study was designed to express in quantitative
terms the impact of neutrophils on the lytic processes in obliterative
vascular thrombi based on the presence of NE-speciﬁc FDPs in the
thrombus structure in relation to the leukocyte, platelet and ﬁbrin
content of thrombi.
Materials and methods
Patients
Twenty-eight patients (15 men and 13 women, mean age:
61 years; range: 46-88 with one extreme value of 19) subjected to
thrombectomy were enrolled in the study. Twenty-ﬁve of them had
obliterative thrombosis localized in large arteries (femoral, ileac,
popliteal, brachial, radial, carotid) based on atherosclerosis in 22 cases
and related to diabetes mellitus in 6 patients (in 11 cases the
thrombus was in a previously implanted graft). Three patients had
venous thrombosis (two of them with renal vein thrombus and one
with pulmonary embolus).With the exception of the youngest patient
with renal vein thrombosis, who had thrombophilia related to
systemic lupus erythematosus, no other inherited or acquired
thrombophilic state could be diagnosed in the examined group. At
the time of thrombectomy all patients received heparin treatment,
whereas in their history 12 patients were treated with low-molecular
weight heparin, 17 patients with anti-aggregatory drugs and 7
patients with oral anticoagulant. In 2 cases clot lysis with tissue-
type plasminogen activator was attempted before the thrombectomy.
Written informed consent was obtained from all patients and the
study protocol was approved by the institutional and regional ethical
board.
Scanning electron microscope (SEM) imaging of thrombi
Immediately after the surgery, 5×5×10 mm pieces of thrombi
were placed into 10 ml 100 mM Na-cacodylate pH 7.2 buffer for 24 h
at 4 °C. Following repeatedwasheswith the same buffer thrombiwere
ﬁxed in 1 v/v% glutaraldehyde for 16 h. The ﬁxed thrombi were
dehydrated in a series of ethanol dilutions (20 – 96 v/v%), 1:1 mixture
of 96 v/v% ethanol/acetone and pure acetone followed by critical point
drying with CO2 in E3000 Critical Point Drying Apparatus (Quorum
Technologies, Newhaven, UK). The specimens were mounted on
adhesive carbon discs, sputter coated with gold in SC7620 Sputter
Coater (Quorum Technologies, Newhaven, UK) and images were
taken with scanning electron microscope EVO40 (Carl Zeiss Gmbh,
Jena, Germany).
Immunohistochemistry
After surgery, the removed thrombus samples were frozen
immediately at −70 °C and stored until examination. Cryosections
(6 μm thickness) of thrombi were attached to silane-coated slides.
Sections were ﬁxed in acetone at 4 °C for 10 min and air-dried for
5 min at room temperature. After further ﬁxation in 4 w/v%
paraformaldehyde (pH 7.0) at 4 °C for 10 min, the sections were
washed in 10 mM Tris-HCl, pH 7.4, containing 150 mM NaCl (TBS) for
5 min, followed by incubation in 100 mMNa-phosphate 100 mMNaCl
pH 7.5 buffer (PBS) containing 5 w/v% bovine serum albumin to
eliminate nonspeciﬁc binding of antibodies. For double immunostain-
ing, sections were ﬁrst incubated overnight at 4 °C in 2 μg/mL mouse
anti-human NE-digested FDPmonoclonal antibody IF-123 (Mitsubishi
Kagaku Iatron, Tokyo, Japan) [16] in TBS. Following washing with PBS,
sections were treated with Alexa Fluor 555 (excitation 555 nm,emission 565 nm) carboxylic acid, succinimidyl ester conjugated
donkey anti-mouse immunoglobulin antibody (Invitrogen, Oregon,
USA) at 1:100 dilution to detect the IF-123. Subsequently slides were
washed in PBS 3 times and blocked with 5 w/v% bovine serum
albumin in PBS, then incubated with 2 μg/mL mouse anti-human
ﬁbrin monoclonal antibody ADI-350 (American Diagnostica, Pfung-
stadt, Germany) or mouse anti-human CD41 (platelet GPIIb/IIIa)
antibody (Biodesign International, Saco, ME) for 30 min at 37 °C
followed by detection of the second immune reactionwith Alexa Fluor
488 (excitation 494 nm, emission 519 nm) 5-carboxamido-(propar-
gyl), bis(triethylammonium salt)) *5-isomer* conjugated goat anti-
mouse antibody (Invitrogen, Oregon, USA) at 1:100 dilution. After
repeated washing with PBS, sections were mounted with 4’,6-
diamidino-2-phenylindole (DAPI), which recognizes DNA, and images
were taken with Eclipse E600 ﬂuorescent microscope (Nikon, Japan)
(Fig. 1).
Image processing
Thrombus images acquired at 808×1104 pixel resolution were
saved in JPEG format. All image pixels were allocated to the whole
area of the thrombus section so that images did not display any
useless information. Image processing was performed by self-devised
Matlab scripts running in Matlab environment (Matlab 6.5.0 Release
13, The MathWorks, Inc., Natick, MA USA). RGB images have three
channels (red, green, and blue) according to the three primary colours
of light and triple system of notation was applied: the NE-degraded
FDPs were allocated to the red channel, the ﬁbrin or platelets were
green and nuclei were blue in the same thrombus section. Thus, the
separation of the thrombus constituents was based upon the image
channels. After importing the thrombus ﬁles into the Matlab software
environment the full colour RGB images were converted to double-
precision images for processing. This process generates three
individual monochromatic images representing the red, green, and
blue components of the original image. This method enabled
automatic and bias-free decomposition of the thrombus image and
spatial localization of the thrombus constituents. The constituent
intensities as a function of the space coordinates are illustrated on 3D
plots in Fig. 1 C-E by color-coded intensity values. All statistical
analyses were performed on integrated intensity values (region of
interest was the whole image) or on intensity values normalized for
leukocyte content (the integrated NE-FDP, ﬁbrin and platelet signal of
each thrombus image divided by the integrated nuclear-stain signal of
the same image).
Statistical analyses
Statistical calculations were implemented using Statistica 8.0
(StatSoft Inc., Tulsa, OK, USA). Linear regression model was applied
for the quantiﬁcation of the association between the neutrophil cell
count and the NE-digested FDP content of the same thrombus sample
on one side, and between the neutrophil cell count in the thrombus
and in the blood samples of the same patient on the other. In order to
identify similarity classes of patients based on the processes going on
in the thrombi, we used hierarchical, agglomerative clustering
analysis applying Ward's amalgamation rule and Euclidean distances
[17]. This multivariate statistical procedure is an approach of
exploratory data analysis, which aims at sorting different objects
revealing meaningful groups in data. Classiﬁcation puts “similar”
thrombi into the same group (cluster), where similarity is deﬁned by
“distance” measures. In our analyses each thrombus (as an object to
be classiﬁed) was described by the following sets of features: 1) a
triplet of amount of elastase-digested ﬁbrin, leukocyte content and
platelet GPIIb/IIIa antigen; 2) a triplet of elastase-digested ﬁbrin,
leukocyte and ﬁbrin content; 3) a duplet of normalized elastase-
digested ﬁbrin and normalized ﬁbrin; 4) a duplet of normalized
Fig. 1. Fibrin, NE-digested ﬁbrin and leukocyte content of arterial thrombi. Sections of surgically removed human thrombi were double-immunostained for ﬁbrin (green) and NE-
digested ﬁbrin (red) as well as with a DNA-dye, DAPI (blue) as described in Methods. Images were taken at original magniﬁcation of ×20 (A) and ×60 (B). The pixel values of the
three color channels (C: red, NE-FDP; D: green, ﬁbrin; E: blue, nuclei) of an image taken as illustrated in panels A and B were decomposed according to the space coordinates of the
thrombus section and their intensity is presented in a color-coded scale.
e96 G. Rábai et al. / Thrombosis Research 126 (2010) e94–e101elastase-digested ﬁbrin and normalized platelet antigen content.
Distances are calculated between every pair of thrombi using these
three or two “coordinates” of the thrombi. Based on the value of the
distances, the applied agglomerative, hierarchical clustering builds
groups by “amalgamation”, pairing the closest objects step-by-step
into constantly growing clusters with increasing population number
and re-calculating the distances between the newly formed larger
groups until a hierarchical tree is formed. The output of the clustering
is a tree diagram (or dendrogram) displaying the joining hierarchy,
which allows the recognition of the main clusters. Cluster merge is
marked by a horizontal line and each node in the graph represents a
branched cluster. The vertical axis measures inter-cluster distance and
each value on the axis refers to a criterion distance at which the
respective clusters were joined into a new single cluster. Since
statistical signiﬁcance testing is not appropriate with this type of
clustering, we used discriminant analysis for the veriﬁcation of the
identiﬁed clusters [17]. Discriminant function analysis tests if the
clusters differ between each other signiﬁcantly, i.e. if they are natural,
distinct classes. All the clusters reported in the Results section proved
to be signiﬁcant with this statistical procedure. For the comparison of
cluster mean and variance values Hotelling's multivariate T2 and F-
statistics was implemented [17].
Results
Leukocytes in the structure of thrombi
SEM images of thrombi provided evidence of leukocytes forming
pseudopodia in-between the ﬁbrin ﬁbers (Fig. 2A). Leukocytes couldbe observed in tight proximity with platelets and differences in
pseudopodium formation indicated that they are in different stages of
activation (Fig. 2B). Because SEM imaging allows only qualitative
morphological evaluation of the interrelations between leukocytes,
platelets and ﬁbrin, the functional aspects of leukocyte presence with
respect to thrombus dissolution were approached with quantitative
data on neutrophil-related ﬁbrin digestion.
Correlation between elastase-digested ﬁbrin and leukocyte content of
thrombi
Based on the ﬂuorescent intensity values for NE-digested FDPs and
nuclear DAPI staining of sections from surgically removed thrombi
(Fig. 1), the association between the elastase-digested ﬁbrin and the
leukocyte content of the thrombi could be quantiﬁed by Pearson
correlation coefﬁcient (Fig. 3), which proved to be signiﬁcant
(r=0.71, p=0.00002). According to the coefﬁcient of determination,
51 percent of the variability of the elastase digested ﬁbrin content
could be attributed to the presence of leukocytes. In general
signiﬁcant correlation does not necessarily imply causation, since
correlation can also emerge from (hidden) common factors without
direct causality. In this case, however, because neutrophils are the
single known sources of NE and these cells represent 76 % of all
leukocytes in thrombi [3], a causal relationship is highly probable. The
remnant 49 percent variability, which cannot be explained by the
quantity of leukocytes in thrombi, is probably related to factors
determining the degree of activation and degranulation of leukocytes.
In line with such a conclusion, no signiﬁcant correlation was found,
when a correlation coefﬁcient between patients’ leukocyte count in
Fig. 2. Leukocytes in the structure of thrombi. SEM images of a thrombus from
pulmonary embolus (A) and implanted arterial graft (B) are shown. In panel A one of
the leukocytes from the left image is focused in a separate frame to emphasize the tight
proximity of the cell pseudopodia and the ﬁbrin ﬁber. In panel B three leukocytes at
different stages of pseudopodium formation surround a platelet. Scale bar=2 μm.
Fig. 3. Correlation between elastase-digested ﬁbrin and leukocyte content of thrombi.
Fluorescence was assigned to NE-FDP or leukocytes according to the approach shown in
Fig. 1. The association of the integrated intensity values (in relative units, RU) for the
two constituents in the same image was evaluated by Pearson's correlation coefﬁcient
(r2 is the coefﬁcient of determination). Different thrombi are indicated by patients’
initials.
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shown). This fact points to the importance of local processes involved
in the formation of thrombi and cell-dependent thrombolysis.
Classiﬁcation of patients based on elastase-digested ﬁbrin, leukocyte and
platelet antigen content in thrombi
Cluster analysis is an exploratory data analytic method, which
does not require any a priori hypotheses about the phenomena under
investigation, but rather lets the data speak. Thus, this analytic
approach has deﬁnite advantages under the clinical conditions of our
study, when little or no objective data are available about the age of
thrombi. When the amount of elastase-digested ﬁbrin, leukocyte
content and platelet GPIIb/IIIa antigen were used for classiﬁcation of
thrombi, two main clusters (ELP1 and ELP2) emerged and these were
veriﬁed by the discriminant function analysis. The size of cluster ELP1
is 18 and the cluster is more homogeneous than cluster ELP2, the size
of which is 10 (Fig. 4A). We attempted to get a better insight into the
clustering principles underlying the existence of these classes of
thrombi by calculating multivariate means and variances of the
clusters. Hotelling's multivariate statistics identiﬁed the clusters as
signiﬁcantly different in their thrombus composition (T2=96.0 F
(3,24)=29.5, pb0.00001). Thrombi isolated from patients of cluster
ELP2 had signiﬁcantly higher elastase-digested ﬁbrin (p=0.0005)
content than thrombi of patients belonging to cluster ELP1 (Fig. 4B).
The difference in platelet-related antigen content was nearly
signiﬁcant (p=0.06). Since F-ratio test indicated inhomogeneity of
variances in both cases, mean values were probed byWelch's method
of separate variance estimate [17]. The mean values for leukocyte
content (estimated from nuclear staining) were also different
(p=0.005), while variances did not differ signiﬁcantly (Table 1).
Moreover, we found that leukocyte content of thrombi predictedelastase-digested ﬁbrin signiﬁcantly in cluster ELP2 (multiple corre-
lation R2=0.58), but not in cluster ELP1 (R2=0.25) (Fig. 4C-D). This
association explains the greater variability of cluster ELP2, and that
consequently it is less homogeneous than cluster ELP1. These results
can be interpreted as a dynamical effect; inhomogeneity (greater
variability) of cluster ELP2 might result from the patients being in a
later phase of cell-related thrombolysis (due to variable invasion of
leukocytes into the thrombus and their activation), while digestion
has just begun in cluster ELP1.
Classiﬁcation of patients based on elastase-digested ﬁbrin, leukocyte and
ﬁbrin content in thrombi
When classiﬁcation was based on this second set of thrombus
features, the same hierarchical, agglomerative clustering approach as
above revealed twomain clusters (ELF1 and ELF2) (Fig. 4E). The size of
cluster ELF1 is 17, whereas that of ELF2 is 11. Hotelling's multivariate
statistics again identiﬁed signiﬁcant differences between the clusters
based on their thrombus composition (T2=36.4 F(3,24)=11.2,
pb0.00009). The two clusters differed both in content of leukocytes
(p=0.009) and elastase-digested ﬁbrin (p=0.00000) according to
univariate comparisons (Fig. 4F), while the amounts of ﬁbrin were not
signiﬁcantly different (Table 2). Thrombi in cluster ELF1 contained
lower numbers of leukocytes and therefore had lower amounts of
elastase-digested ﬁbrin. The variances of all constituents are signiﬁ-
cantly higher in cluster ELF2. Although these thrombiwere sampled in
a different session, the impression they produced about the dynamics
of thrombolysis was similar to the one mentioned above in relation to
ELP1 and ELP2.
Evaluation of the thrombus constituents’ content (elastase-digested
ﬁbrin, platelet GPIIb/IIIa antigen and ﬁbrin) as a normalized function of
the leukocyte content
Because we found that thrombi showed signiﬁcantly varying
leukocyte content, potential interrelations of the other examined
characteristics (amount of ﬁbrin, NE-FDP and platelet in thrombi) can
be evaluated on the basis of a parameter, which is independent of the
leukocyte effects. To this end we applied normalization of the
ﬂuorescent signals by unit amount of leukocyte. Normalized values
for NE-FDP, ﬁbrin and platelet antigen were derived by dividing the
Fig. 4. Clustering of patients according to the elastase-digested ﬁbrin, leukocyte, platelet antigen and ﬁbrin content of their thrombi. The thrombus constituents were quantiﬁed as
illustrated in Fig. 1. Based on the NE-FDP, leukocyte and platelet antigen content two main clusters of patients (ELP1 and ELP2) were revealed by hierarchical, agglomerative
clustering technique using Ward's method and Euclidean distances (A) and two main clusters (ELF1 and ELF2) were identiﬁed on the basis of NE-FDP, leukocyte and ﬁbrin content
(E). In panel B univariate comparison of the NE-FDP (red), leukocyte (blue) and platelet (green) content in clusters ELP1 and ELP2 is shown, whereas panel F presents the same
analysis for clusters ELF1 and ELF2, where the green color stands for ﬁbrin (mean and 95 % conﬁdence intervals are indicated). Multiple correlation analysis was performed
separately for the patients belonging to the clusters ELP1 shown with red symbols and ELP2 shown with green symbols (C, D).
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by their nuclear-stain signal.
Such an evaluation points to the role of additional local factors (e.g.
temporal dynamics) superimposed on the cell-dependent thrombo-
lysis. Clustering analysis was performed in two duplets of features: 1)
normalized NE-FDP and normalized ﬁbrin; 2) normalized platelet
antigen and normalized NE-FDP. According to the ﬁrst set of
characteristics three clusters of patients emerged (Fig. 5A): REF1,REF2 and REF3. The thrombi in cluster REF1 contained small amounts
of normalized NE-FDP and normalized ﬁbrin. Cluster REF2 was
characterized by higher amounts of normalized NE-FDP and even
higher amounts of normalized ﬁbrin. In cluster REF3 the normalized
NE-FDP showed inverse ratio to the normalized ﬁbrin. These
characteristics of the REF1, REF2 and REF3 clusters can be interpreted
in terms of the dynamics of thrombus development. At low ﬁbrin
content low cell-dependent thrombolytic activity is expressed (REF1).
Table 1
Characteristics of patient clusters according to the content of elastase-digested ﬁbrin, leukocytes and platelet antigen in thrombi. Sections of surgically removed thrombi were
double- immunostained for NE-FDP and platelet GPIIb/IIIa antigen, leukocytes were identiﬁed by using nuclear staining. The thrombus constituents were quantiﬁed from the section
images as described in Methods and the characteristics of the two patient clusters (ELP1 and ELP2) identiﬁed in Fig. 4A are presented.
Thrombus constituent mean cluster ELP1 mean cluster ELP2 t df p SD cluster ELP1 SD cluster ELP2 F-ratio variances p variances
NE-FDP 30157 121835 −5.04* 9.8 0.0005 16126.4 56218.2 12.2 0.000017
leukocyte 53069 85803 −3.10 26 0.005 22798.7 33067.0 2.1 NS
platelet 13967 47095 −2.10* 9.6 0.06 11933.7 49325.4 17.1 0.000002
* Student t-test with separate variance estimate.
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ﬁbrin increases) especially in the case of patients CSS, PL and NN,
whose thrombi contained both higher amounts of ﬁbrin and digested
ﬁbrin. In these three patients an inverse relationship between the
digested and undigested ﬁbrin appeared according to linear regres-
sion with a negative slope of -0.3977. The linear regression of all data
for cluster REF3 shows the same slope (Fig. 5A) and proved to be
signiﬁcant (p=0.0025).
When normalized platelet antigen and normalized NE-FDP were
used as characterizing variables in the cluster analysis, we gained
insights into the role of platelets in cell-dependent ﬁbrinolysis.
Clustering classiﬁed the patients’ thrombi into two groups (Fig. 5B):
REP1 and REP2. Thrombi of cluster REP1 were characterized by
relatively small amounts of normalized NE-FDP and normalized
platelet antigen was also low. In cluster REP2 normalized NE-FDP was
in inverse ratio to normalized platelet antigen. It is plausible to
assume that the cell-dependent ﬁbrinolytic process was scarcely
progressed in cluster REP1, but was very intense in cluster REP2. Thus,
the degree of cell-dependent ﬁbrinolysis is inversely proportional to
the content of platelet antigen. The relationships between platelet and
NE-FDP can also be described by linear regression in both REP1 and
REP2 clusters, although the slopes (−0.2813 and −0.5307, respec-
tively) do not differ signiﬁcantly from zero.
Discussion
Despite the early histological evidence for the role of neutrophilic
leukocytes in the removal of ﬁbrin [9,10], little is known about the
quantitative signiﬁcance of this alternative thrombolytic route in vivo.
Using antibody raised against the NE-speciﬁc FDPs [16], three studies
conﬁrmed the elevation of these ﬁbrinolytic products in the plasma of
patients with disseminated intravascular coagulation and deep vein
thrombosis, as well as after cardiopulmonary bypass surgery and
major abdominal surgery [18–20], but no information is available on
the local content of elastase-digested ﬁbrin in human thrombi. The
demand to acquire such information in humans is justiﬁed by the data
from plasminogen knock-out mice [21], which show increased
inﬁltration of thrombi by polymorphonuclear leukocytes, suggesting
their compensatory role if the plasmin-dependent thrombolysis is
deﬁcient. Our study was undertaken in attempt to characterize in
quantitative terms the local contribution of neutrophil elastase to the
overall thrombolytic process in humans. Thrombi of twenty-eight
patients subjected to thrombectomy were studied for the presence of
NE-digested ﬁbrin, platelet GPIIb/IIIa antigen, ﬁbrin and nucleated
cells. The single criterion for patient selection was the surgical
indication for thrombectomy. Thus, the pathological background andTable 2
Characteristics of patient clusters according to the content of elastase-digested ﬁbrin, leu
immunostained for NE-FDP and ﬁbrin antigen, leukocytes were identiﬁed by using nuclear st
in Methods and the characteristics of the two patient clusters (ELF1 and ELF2) identiﬁed in
Thrombus constituent mean cluster ELF1 mean cluster ELF2 t df
NE-FDP 29937 65072 2.83* 23.9
leukocyte 62553 196563 6.77* 25.4
ﬁbrin 18233 45381 1.94* 24.9
* Student t-test with separate variance estimate.localization of thrombi were heterogeneous, but most of the
examined thrombi (22 out of 28) were atherosclerosis-related.
Simple visual inspection of the images of triple-stained thrombus
sections produced the impression of a massive presence of NE-
digested ﬁbrin (Fig. 1A) and co-localization of nucleated cells and NE-
FDP (Fig. 1B) in accordance with the visualization of activated
leukocytes within the ﬁbrin meshwork of thrombi (Fig. 2). However,
objective analysis of the cumulative image data requires a quantita-
tive and bias-free approach. Pixel decomposition of the truecolor
images (Fig. 1C-E) provides a tool to allocate the intensity values of
the separate color channels in space and thus the distribution of the
thrombus constituents can be quantitatively characterized. This image
processing technique allowed statistically sound conclusions from the
global evaluation of the 28 patients’ thrombi. Thus, the visual
impression of co-localization of NE-FDP and leukocytes was in line
with the signiﬁcant Pearson correlation coefﬁcient between the
elastase-digested ﬁbrin and the leukocyte content of the thrombi
(Fig. 3). The effect of the local accumulation of leukocytes in thrombi
[3] seems to be causal with respect to the generation of NE-FDP. Our
study is the ﬁrst to verify quantitatively the in vivo association of the
local presence of leukocytes and the cell-dependent degradation of
ﬁbrin. Because most of the thrombi evaluated in this study were of
atherosclerotic origin, the cell-related thrombolysis may be a
signiﬁcant aspect of the resolution of atherothrombotic clots.
The platelet content of 10 mL blood is concentrated in a 400-μL
volume of thrombi [22]. Consequently, it is essential to evaluate the
thrombus platelet content in association with the local indicators of
cell-dependent thrombolysis. In our analysis of thrombi with
heterogeneous pathological origin and localization no a priori
distinction criteria were used, all interrelations were established
with bias-free statistical evaluation of the quantitative data from the
complete set of available samples. When thrombi were classiﬁed
according to the combination of platelet-, NE-FDP and leukocyte-
related signals, two deﬁnite classes could be identiﬁed (Fig. 4A): a
more homogeneous ELP1 cluster with lower NE-FDP, leukocyte and
platelet content and a more heterogeneous ELP2 cluster with higher
NE-FDP, leukocyte and platelet content. This reﬁned classiﬁcation
shows that a subclass of patients (ELP1) could be discriminated, in
which no correlation between leukocytes and NE-FDP exists, whereas
in the more variable cluster (ELP2) a straightforward correlation of
these two parameters could be established, which inevitably is
stronger than the one in the general group of patients. A plausible
explanation for the differences observed in the two classes of thrombi
might be their age: the younger thrombi of ELP1 were scarcely
affected by cell-dependent thrombolysis, whereas the aged ELP2
thrombi were in a more progressed stage of resolution. In the absencekocytes and ﬁbrin in thrombi. Sections of surgically removed thrombi were double-
aining. The thrombus constituents were quantiﬁed from the section images as described
Fig. 4E are presented.
p SD cluster ELF1 SD cluster ELF2 F-ratio variances p variances
0.009 20223.7 44486.9 4.8 0.01
0.0000 36721.8 67711.5 3.4 0.05
0.06 24594.0 48776.9 3.9 0.03
Fig. 5. Elastase-digested ﬁbrin, platelet GPIIb/IIIa antigen and ﬁbrin content of thrombi
normalized to their leukocyte content. The integrated ﬂuorescence values for NE-FDP,
platelet antigen and ﬁbrin are divided by the integrated intensity for leukocytes in the
same images. Cluster analysis was performed according to the combination of
normalized NE-FDP and ﬁbrin (A), which identiﬁed three classes of patients (REF1,
blue; REF2, red; REF3, green), or the combination of normalized NE-FDP and platelet
antigen (B), which indicates two classes of patients (REP1, blue; REP2, red). Continuous
lines represent the linear regression analysis of all data in the cluster shown with the
same color, whereas the dashed line indicates the regression to the data of only three
patients (CSS, PL and NN).
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remains hypothetic and its conﬁrmation requires future studies. If
cluster analysis is performed according to the combination of ﬁbrin-,
NE-FDP and leukocyte-related signals, two deﬁnite classes could be
identiﬁed (Fig. 4E), but their constituents differ less than in the
classiﬁcation involving platelet content. This suggests a more
signiﬁcant role for platelets (than the total ﬁbrin content) as a
determinant of the cell-dependent thrombolysis, which is probably
related to the localization of the thrombi examined in the present
study (most of them are arterial, known to have higher platelet
content than venous thrombi).
In order to eliminate the impact of the variable leukocyte content,
the signals related to thrombus constituents (NE-FDP, ﬁbrin, plate-
lets) were normalized to the leukocyte signal and cluster analysis was
performed on the basis of normalized NE-FDP and ﬁbrin (yielding
three classes: REF1, REF2 and REF3) or normalized NE-FDP and
platelet values (yielding two classes: REP1 and REP2) (Fig. 5).
Normalization by leukocyte content served to reveal the inverse
relationship between the intact ﬁbrin and NE-digested ﬁbrin content,
which did not emerge from the raw data. Thus, we found that the
invasion of leukocytes in the thrombus could change its state as afunction of the total ﬁbrin content. Based on the characteristics of the
REF1, REF2 and REF3 clusters, a dynamic picture of thrombus
development emerges. At low ﬁbrin content, low cell-dependent
thrombolytic activity is expressed (REF1), which increases with the
increase in ﬁbrin (REF2) and reaches a dominant role, which curtails
the ﬁbrin content in the most advanced phase (REF3). It is worth
noting that in spite of the fact that our analyses of thrombi represent
just a momentary snapshot taken at the time of thrombectomy, they
revealed several dynamic aspects and indirectly provided information
on the temporal course of thrombus development and the relative
prothrombotic and thrombolytic activity of the cells localized in the
thrombi. The inverse relationship of NE-FDP and platelet antigen in
the REP2 cluster points to the clot-stabilizing role of platelets against
cell-dependent thrombolysis, which is in agreement with our earlier
in vitro observations fromNE-perfused platelet clots [23], whereas the
association of low NE-FDP and low platelet content in REP1 is
probably related to a low-level leukocyte stimulation by platelets [4]
in this cluster.
In summary, quantitatively signiﬁcant cell-dependent ﬁbrinolytic
activity in obliterative thrombi correlates with the invasion of
leukocytes, the thrombolytic activity of which, in addition, shows
dynamic interrelation with the thrombus ﬁbrin and platelet content.
Our structural data substantiate the need for further studies to clarify
the causal interrelations between the ﬁbrin and platelet content on
one hand and the cell-dependent thrombolysis on the other.
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